Carisoprodol
Product Images NDC 70934-663

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Carisoprodol (NDC 70934-663). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (70934 663 30 Master Bottle Label Approval Rev A 04 20)

CARISOPRODOL Tablets USP 350 mg bottle label by Denton Pharma, Inc. dba Northwind Pharmaceuticals, containing 30 tablets. The label includes storage instructions to keep at 20°-25°C and warnings to keep out of reach of children, with dosage direction to see package insert. It shows the drug is prescription only and includes various NDC and manufacturing details.*

FDA Label Image

Structural Formula Of Carisoprodol (Structure)

Chemical structure of Carisoprodol showing its molecular composition and arrangement of atoms, including carbon, hydrogen, nitrogen, and oxygen atoms that constitute the muscle relaxant compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.